Abstract
We assessed referring medical practitioner's ability to predict chronic fatigue development in adolescents presenting with acute infectious mononucleosis. The physicians answered "yes", "no" or "don't know" to whether the teenager would develop chronic fatigue six months later, and the Chronic Fatigue Questionnaire was used to measure actual fatigue-state. The odds ratio (OR) for chronic fatigue when predicted as unsurely fatigued (not fatigued was reference category) was 2. 
INTRODUCTION

Infectious mononucleosis (IM), normally caused by Epstein-Barr virus (EBV), is a common
infection in adolescence and a well-known trigger of chronic fatigue and chronic fatigue syndrome (CFS); in one study, 13 % of IM-patients were diagnosed with CFS six months after acute EBV-infection. [1] Results from the CEBA-project (Chronic fatigue following acute EBV infection in adolescents) suggest that baseline symptoms and functional abilities are stronger predictors of fatigue development than markers of infection or immune responses. [2] In the present CEBA sub-study, we aimed at assessing the referring medical practitioners' ability to predict fatigue development based upon their initial encounter with EBV-infected adolescents.
METHOD
The CEBA-project (ClinicalTrial ID: NCT02335437) is a cohort study of fatigue development in adolescents after acute EBV infection. The CEBA-project has been approved by the Norwegian Committee for Ethics in Medical research. Participation was based on written informed consent.
Individuals with a serological pattern indicating acute EBV-infection, age between 12 and 20 years and living in South-East Norway were eligible for participation in CEBA; exclusion criteria were more than six weeks since debut of symptoms, medication due to chronic disease, and pregnancy. Study patients were investigated during the acute infection episode (baseline) and six months later; details of the investigational program are provided elsewhere. [2] Fatigue (predefined primary endpoint) was assessed by the Chalder Fatigue Questionnaire (CFQ); dichotomous scoring (0-0-1-1) was applied, and a total score of four or higher was considered a case of chronic fatigue (CF). [3] 
In addition, at baseline, a short questionnaire was administered to the physicians who requisitioned the primary EBV analyses, asking them to answer "Yes", "No" or "Don't know" to whether the particular teenager would develop chronic fatigue six months later or not. The questionnaire also charted initial symptoms and signs during the consultation, and simple demographic information. 
Statistics
RESULTS
A total of 200 patients with acute EBV infection were included in the CEBA-project; five were lost to follow up six months later. A total of 165 physicians returned the questionnaire, yielding a complete dataset for 161 patients that were subjected to further analyses. Neither the patient's sex nor CRP nor the doctors level of experience had significant impact on the OR estimate when included in the model.
DISCUSSION
The present report shows that physician's prediction of fatigue development following an acute EBV infection significantly corresponds to actual fatigue status six months later. The considerations underlying these predictions are unknown; notably, neither sex, CRP nor the referring physician's level of experience impacted on the regression model, suggesting that they [3] In the present CEBA sub-study, we aimed at assessing the referring medical practitioners' ability to predict fatigue development based upon their initial encounter with EBV-infected adolescents.
METHOD
The CEBA-project (ClinicalTrial ID: NCT02335437) is a post-infectious cohort study of fatigue development in adolescents after acute EBV infection. The CEBA-project has been approved by the Norwegian Committee for Ethics in Medical research. Participation was based on written informed consent.
Individuals with a serological pattern indicating acute EBV-infection, age between 12 and 20 years and living in South-East Norway were eligible for participation in CEBA; exclusion criteria were more than six weeks since debut of symptoms, medication due to chronic disease, and pregnancy. Patients enrolled in the study were extensively investigated during the acute infection episode (baseline) and six months later; details of the investigational program are provided elsewhere. [3] Fatigue (predefined primary endpoint) was assessed by the Chalder Fatigue Questionnaire (CFQ); dichotomous scoring (0-0-1-1) was applied, and a total score of four or higher was considered a case of chronic fatigue (CF). [4] In addition, at baseline, a short questionnaire was administered to the physicians who requisitioned the primary EBV analyses (see supplementary file), asking them to guess whether the particular teenager would develop chronic fatigue six months later or not; possible answers were "Yes", "No" and "Don't know". The questionnaire also charted initial symptoms and signs during the consultation, as well as simple demographic information. were included in the model. A p-value of < 0.05 was considered statistically significant.
RESULTS
A total of 200 patients with acute EBV infection were included in the CEBA-project; five of these were lost to follow up six months later. A total of 165 physicians returned the questionnaire, yielding a complete dataset for 161 patients that were subjected to further analyses. 
DISCUSSION
The present report shows that the physician's prediction of fatigue development following an acute EBV infection significantly relates to actual fatigue status six months later. The considerations underlying these predictions are unknown; notably, adding neither sex, CRP nor the referring physician's work experience to the regression model impacted on the effect 
INTRODUCTION
Infectious mononucleosis (IM), normally caused by Epstein-Barr virus (EBV), is a common
infection in adolescence and a well-known trigger of chronic fatigue (CF) and chronic fatigue syndrome (CFS); 11-13,5 % of IM-patients are diagnosed with CFS six months after acute EBVinfection. [1] [2] [3] The present study is part of the CEBA-project (Chronic fatigue following acute EBV-infection in adolescents), and in this research letter we aimed at assessing the referring medical practitioners' ability to predict fatigue development based upon their initial encounter with EBV-infected adolescents.
METHOD
The CEBA-project (ClinicalTrial ID: NCT02335437) has been approved by the Norwegian Committee for Ethics in Medical research. Participation was based on written informed consent.
Patients were not directly involved in the design of the CEBA-project.
Individuals with a serological pattern indicating acute EBV-infection, age between 12 and 20 years and living in South-East Norway were eligible for participation in CEBA; exclusion criteria were more than six weeks since debut of symptoms, medication due to chronic disease, and pregnancy. Patients enrolled in the study were extensively investigated during the acute infection episode (baseline) and six months later; details of the investigational program are provided elsewhere. [3] Fatigue (predefined primary endpoint) was assessed by the Chalder Fatigue Questionnaire (CFQ); bimodal scoring (0-0-1-1) was applied, and in line with earlier studies, a total score of four or higher was considered a case of CF. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 were included in the model. A p-value of < 0.05 was considered statistically significant.
RESULTS
A total of 200 patients with acute EBV infection were included in the CEBA-project; five were lost to follow up six months later. A total of 165 physicians returned the questionnaire, yielding a complete dataset for 161 patients that were subjected to further analyses. A comparison of patients from physicians that returned and did not return the questionnaire showed no significant difference (Table 1) . Compared with "not fatigued", being predicted as "unsurely fatigued" and "likely fatigued"
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